Wells' syndrome with a clinicopathological correlation associated with mantle-cell lymphoma

Leuk Lymphoma. 2016 Nov;57(11):2702-4. doi: 10.3109/10428194.2016.1157876. Epub 2016 Mar 21.

Authors

Ilias Pessach¹, Kyriaki Petevi¹, Kostas Gkirkas¹, Maria Stamouli¹, Pavlos Constantinou², Dimitra Rontogianni², Georgios Dimitriadis¹, Panagiotis Tsirigotis¹

Affiliations

¹ a Second Department of Internal Medicine, 'ATTIKON' General University Hospital, Medical School , University of Athens , Greece ;
² b Department of Pathology , Evaggelismos General Hospital , Athens , Greece.

PMID: 26999270
DOI: 10.3109/10428194.2016.1157876

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cellulitis / drug therapy
Cellulitis / etiology*
Cellulitis / pathology
Cyclophosphamide / therapeutic use
Doxorubicin / therapeutic use
Eosinophilia / drug therapy
Eosinophilia / etiology*
Eosinophilia / pathology
Humans
Lymphoma, Mantle-Cell / complications*
Lymphoma, Mantle-Cell / drug therapy
Lymphoma, Mantle-Cell / pathology
Male
Middle Aged
Prednisone / therapeutic use
Rituximab
Vincristine / therapeutic use

Substances

Antibodies, Monoclonal, Murine-Derived
R-CHOP protocol
Rituximab
Vincristine
Doxorubicin
Cyclophosphamide
Prednisone

Supplementary concepts

Wells syndrome